Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
GLAXOSMITHKLINE LLC v. TEVA PHAMACEUTICALS USA, INC.
Case Number:
2:15-cv-02689
Court:
Nature of Suit:
Other Statutes: Other Statutory Actions
Judge:
Firms
-
September 14, 2015
GSK False Ad Suit Over Teva's Generic Wellbutrin Frozen
A Pennsylvania federal judge on Friday suspended a false advertising suit by GlaxoSmithKline LLC against Teva Pharmaceuticals USA Inc. over Teva's marketing of its generic Wellbutrin as equivalent to the brand-name drug, though another similar suit is going forward.
-
May 15, 2015
GSK Files New Suit Against Teva Over Generic Wellbutrin
GlaxoSmithKline LLC on Thursday filed a second lawsuit in Pennsylvania federal court against Teva Pharmaceuticals USA Inc. over a generic version of Wellbutrin XL, this time alleging Teva's false advertising that its generic was comparable to the antidepressant cost GSK's business partner millions.